Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NWPHF

Newron Pharmaceuticals S.p.A.

USD

Set alert

Price alert · NWPHF

All alert types
20.00 USD 0.00 0.00%
As of Oct 29, 2026
9.36 Day range 9.36
9.36 52-week range 20.00
YTD
+113.68%
1 year
+113.68%
Open
9.36
Prev close
20.00
Mkt cap
408.95M
Vol
986
Avg vol
0
EPS
-0.74
P/E
0.00
More statistics
Low
9.36
High
9.36

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NWPHF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.82 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -25.8×
FY 2016: -5.7×FY 2017: -16.2×FY 2018: -6.5×FY 2019: -4.9×FY 2020: -4.3×FY 2021: -6.5×FY 2022: -5.9×FY 2023: -7.1×FY 2024: 10.8×FY 2025: -25.8×
FY 2016 5y median -6.5× FY 2025
P/S 17.8×
FY 2016: 12.9×FY 2017: 6.3×FY 2018: 24.0×FY 2019: 14.1×FY 2020: 17.3×FY 2021: 16.9×FY 2022: 17.0×FY 2023: 12.7×FY 2024: 3.3×FY 2025: 17.8×
FY 2016 5y median 16.9× FY 2025
P/B -30.5×
FY 2016: 1.7×FY 2017: 1.2×FY 2018: 1.8×FY 2019: 2.7×FY 2020: 5.3×FY 2021: 31.4×FY 2022: -7.4×FY 2023: -3.8×FY 2024: 117×FY 2025: -30.5×
FY 2016 5y median -3.8× FY 2025
P/FCF 10.5×
FY 2016: -4.4×FY 2017: -10.0×FY 2018: -6.1×FY 2019: -4.5×FY 2020: -5.8×FY 2021: -8.5×FY 2022: -9.3×FY 2023: -11.3×FY 2024: -9.7×FY 2025: 10.5×
FY 2016 5y median -9.3× FY 2025
EV/EBITDA -47.0×
FY 2016: -2.9×FY 2017: -10.8×FY 2018: -4.7×FY 2019: -4.8×FY 2020: -6.1×FY 2021: -9.8×FY 2022: -10.2×FY 2023: -13.2×FY 2024: 8.3×FY 2025: -47.0×
FY 2016 5y median -10.2× FY 2025
EV/Sales 19.1×
FY 2016: 6.6×FY 2017: 3.3×FY 2018: 17.3×FY 2019: 13.3×FY 2020: 19.8×FY 2021: 20.1×FY 2022: 22.3×FY 2023: 17.3×FY 2024: 4.2×FY 2025: 19.1×
FY 2016 5y median 19.1× FY 2025
FCF Yield 9.5%
FY 2016: -22.7%FY 2017: -10.0%FY 2018: -16.5%FY 2019: -22.3%FY 2020: -17.2%FY 2021: -11.7%FY 2022: -10.7%FY 2023: -8.9%FY 2024: -10.3%FY 2025: 9.5%
FY 2016 5y median -10.3% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 60.8%FY 2017: 100.0%FY 2018: 65.9%FY 2019: 79.8%FY 2020: 94.4%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -24.6%
FY 2016: -227.8%FY 2017: -30.5%FY 2018: -372.1%FY 2019: -296.9%FY 2020: -343.6%FY 2021: -214.5%FY 2022: -218.3%FY 2023: -128.4%FY 2024: 50.9%FY 2025: -24.6%
FY 2016 5y median -128.4% FY 2025
Net Margin -69.2%
FY 2016: -226.5%FY 2017: -39.3%FY 2018: -373.5%FY 2019: -287.1%FY 2020: -399.4%FY 2021: -258.6%FY 2022: -287.1%FY 2023: -179.1%FY 2024: 30.8%FY 2025: -69.2%
FY 2016 5y median -179.1% FY 2025
ROE 118.9%
FY 2016: -30.6%FY 2017: -7.8%FY 2018: -27.4%FY 2019: -54.9%FY 2020: -121.8%FY 2021: -479.6%FY 2022: 124.7%FY 2023: 54.2%FY 2024: 1086.6%FY 2025: 118.9%
FY 2016 5y median 118.9% FY 2025
ROIC -17.1%
FY 2016: -30.5%FY 2017: -6.0%FY 2018: -26.9%FY 2019: -52.0%FY 2020: -56.7%FY 2021: -33.9%FY 2022: -55.1%FY 2023: -60.0%FY 2024: 35.9%FY 2025: -17.1%
FY 2016 5y median -33.9% FY 2025
ROA -33.1%
FY 2016: -26.9%FY 2017: -7.2%FY 2018: -25.1%FY 2019: -33.5%FY 2020: -41.0%FY 2021: -29.5%FY 2022: -47.0%FY 2023: -62.7%FY 2024: 24.8%FY 2025: -33.1%
FY 2016 5y median -33.1% FY 2025

Growth (YoY)

Revenue -62.8%
FY 2016: 182.6%FY 2017: 99.6%FY 2018: -70.0%FY 2019: 74.9%FY 2020: -25.3%FY 2021: 9.6%FY 2022: 5.8%FY 2023: 48.6%FY 2024: 467.4%FY 2025: -62.8%
FY 2016 FY 2025
Operating Income -117.9%
FY 2016: 13.3%FY 2017: 73.3%FY 2018: -265.7%FY 2019: -39.5%FY 2020: 13.6%FY 2021: 31.6%FY 2022: -7.6%FY 2023: 12.6%FY 2024: 325.1%FY 2025: -117.9%
FY 2016 FY 2025
EPS (diluted) -177.6%
FY 2016: 37.3%FY 2017: 69.2%FY 2018: -162.5%FY 2019: -34.5%FY 2020: -4.4%FY 2021: 28.8%FY 2022: -16.7%FY 2023: 7.1%FY 2024: 193.4%FY 2025: -177.6%
FY 2016 FY 2025
Free Cash Flow 283.2%
FY 2016: -52.1%FY 2017: 57.1%FY 2018: -89.7%FY 2019: -37.8%FY 2020: 29.1%FY 2021: 26.6%FY 2022: 3.1%FY 2023: 8.6%FY 2024: -73.6%FY 2025: 283.2%
FY 2016 FY 2025

Financial Health

Current Ratio 0.8×
FY 2016: 8.4×FY 2017: 15.4×FY 2018: 13.4×FY 2019: 8.1×FY 2020: 5.5×FY 2021: 10.8×FY 2022: 5.7×FY 2023: 0.7×FY 2024: 2.6×FY 2025: 0.8×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 0.8×
FY 2016: 8.4×FY 2017: 15.4×FY 2018: 13.4×FY 2019: 8.1×FY 2020: 5.5×FY 2021: 10.8×FY 2022: 5.7×FY 2023: 0.7×FY 2024: 2.6×FY 2025: 0.8×
FY 2016 5y median 2.6× FY 2025
Debt / Equity -3.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.5×FY 2020: 1.5×FY 2021: 13.9×FY 2022: -3.3×FY 2023: -1.6×FY 2024: 34.6×FY 2025: -3.4×
FY 2016 5y median -1.6× FY 2025
Net Debt / EBITDA -3.3×
FY 2016: 2.8×FY 2017: 10.0×FY 2018: 1.9×FY 2019: 0.3×FY 2020: -0.8×FY 2021: -1.5×FY 2022: -2.4×FY 2023: -3.6×FY 2024: 1.7×FY 2025: -3.3×
FY 2016 5y median -2.4× FY 2025
Interest Coverage -1.1×
FY 2016: -116×FY 2017: -48.2×FY 2018: -267×FY 2019: -36.5×FY 2020: -8.1×FY 2021: -4.2×FY 2022: -3.0×FY 2023: -2.8×FY 2024: 6.0×FY 2025: -1.1×
FY 2016 5y median -2.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31